StonvexLoading…
StonvexStonvexStonvexCore line items from FPH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $13.04M | $108.16M | $32.74M | $19.78M |
Operating Income | $-5.91M | $212.46M | $144.94M | $80.03M |
Net Income | $-2.23M | $70.97M | $47.67M | $26.60M |
EPS (Diluted) | Not available | Not available | Not available | Not available |
Total Assets | $3.19B | $3.25B | $3.19B | $3.16B |
Total Liabilities | $810.04M | $860.41M | $835.77M | $908.68M |
Cash & Equivalents | $332.57M | $425.55M | $351.13M | $456.64M |
Free Cash Flow OCF − CapEx | $-44.50M | $105.01M | $25.42M | $-15.00M |
Shares Outstanding | Not available | Not available | Not available | Not available |